IHH Healthcare Berhad | Annual Report 2024 72 Corporate Governance Overview Statement Governance Our Commitment to Good Corporate Governance At IHH Healthcare Berhad (IHH or the Company), together with its subsidiaries (the Group), we firmly believe that robust corporate governance practices are crucial for delivering shareholder value, enhancing business integrity, maintaining investor confidence and achieving the Group’s corporate objectives and vision. The Board, Management and employees of the Group are committed to upholding the highest standards of corporate governance. We continuously strive to refine the Group’s corporate governance practices and processes, ensuring that we consistently uphold the pillars of corporate governance such as ethical behaviour, accountability, transparency and sustainability. The Board is committed to ensuring that the Group’s Corporate Governance Framework adheres to the following requirements and guidelines: • Companies Act 2016; • Malaysian Code on Corporate Governance (MCCG); • Main Market Listing Requirements (MMLR) of Bursa Malaysia Securities Berhad (Bursa Securities); and • Bursa Securities Corporate Governance Guide. The Board is pleased to present this statement, pursuant to Paragraph 15.25 of the MMLR, for the financial year ended 31 December 2024 (CG Overview Statement) in respect of the following principles: • Principle A – Board Leadership and Effectiveness; • Principle B – Effective Audit and Risk Management; and • Principle C – Integrity in Corporate Reporting and Meaningful Relationship with Stakeholders. The CG Overview Statement shall be read together with the Corporate Governance Report 2024, which is available on the Company’s website at https://www. ihhhealthcare.com/investors/corporategovernance/corporate-governance-reports. The IHH Corporate Governance Framework is designed to ensure the orderly and effective discharge of the Board’s roles and responsibilities. To achieve this, specific roles and responsibilities of the Board are delegated to the relevant Board Committees, the Group Chief Executive Officer (GCEO) and various Management committees. This delegation structure is illustrated at the end of this page. Principle A – Board Leadership and Effectiveness 1. Board Responsibilities The Board directs and oversees the management of the business and affairs of IHH and the Group, with the primary goal of achieving long-term success of the Company and delivering sustainable value to all stakeholders. Beyond making major policy decisions, the Board determines the strategic direction of the Company, ensures that the necessary resources are available to meet its objectives and oversees the Management’s execution of strategy and financial performance. In collaboration with Management, the Board sets the tone from the top by providing thought leadership, championing a culture of good corporate governance within the Company and formalising and upholding ethical values throughout the organisation. Organisation Stakeholders Legislations and Compliance Strategy Vision, Mission and Core Values Policies and Procedures Quality and Assurance Corporate Governance Framework Nomination and Remuneration Committee Risk Management Committee International Clinical Governance Advisory Council Audit Committee Group Chief Executive Officer Internal Audit Sustainability Committee (Chaired by Group Chief Executive Officer) Group Management Operating Companies’ Management Team Company Secretary Board of Directors
RkJQdWJsaXNoZXIy NDgzMzc=